Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ALEXANDER, John H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 72

  • Page / 3
Export

Selection :

  • and

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesHYLEK, Elaine M; HELD, Claes; THOMAS, Laine et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 20, pp 2141-2147, issn 0735-1097, 7 p.Article

Influence of body mass index on the efficacy of revascularization in patients with coronary artery diseaseTURER, Aslan T; MAHAFFEY, Kenneth W; HONEYCUTT, Emily et al.Journal of thoracic and cardiovascular surgery (Print). 2009, Vol 137, Num 6, pp 1468-1474, issn 0022-5223, 7 p.Article

Coronary Artery Bypass Graft Failure After On-Pump and Off-Pump Coronary Artery Bypass : Findings From PREVENT IV. DiscussionMAGEE, Mitchell J; ALEXANDER, John H; MACK, Michael J et al.The Annals of thoracic surgery. 2008, Vol 85, Num 2, pp 494-500, issn 0003-4975, 7 p.Conference Paper

Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction : a phase II dose-ranging studyDZAVIK, Vladimir; COTTER, Gad; PRONDZINSKY, Roland et al.European heart journal. 2007, Vol 28, Num 9, pp 1109-1116, issn 0195-668X, 8 p.Article

Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery diseaseBORGES-NETO, Salvador; SHAW, Linda K; TUTTLE, Robert H et al.The American journal of cardiology. 2005, Vol 95, Num 2, pp 182-188, issn 0002-9149, 7 p.Article

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials NetworkSMITH, Peter K; MICHLER, Robert E; MOQUETE, Ellen et al.Journal of thoracic and cardiovascular surgery (Print). 2012, Vol 143, Num 1, pp 111-117, issn 0022-5223, 7 p.Article

Apixaban with Antiplatelet Therapy after Acute Coronary SyndromeALEXANDER, John H; LOPES, Renato D; HUBER, Kurt et al.The New England journal of medicine. 2011, Vol 365, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft SurgeryDOMANSKI, Michael J; MAHAFFEY, Kenneth; BRODERICK, Samuel et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 6, pp 585-591, issn 0098-7484, 7 p.Article

Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyMEHTA, Rajendra H; STEBBINS, Amanda; ALEXANDER, John H et al.The American journal of medicine. 2011, Vol 124, Num 1, pp 48-57, issn 0002-9343, 10 p.Article

The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trialVAVALLE, John P; STEVENS, Susanna R; HASSINGER, Nancy et al.The American heart journal. 2011, Vol 162, Num 6, pp 996-1002, issn 0002-8703, 7 p.Article

Thrombomodulin Gene Variants Are Associated With Increased Mortality After Coronary Artery Bypass Surgery in Replicated AnalysesLOBATO, Robert L; WHITE, William D; MATHEW, Joseph P et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 11, issn 0009-7322, S143-S148, SUP1Conference Paper

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery : MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II-study design and rationaleMEHTA, Rajendra H; ALEXANDER, John H; EMERY, Robert et al.The American heart journal. 2008, Vol 155, Num 4, pp 600-608, issn 0002-8703, 9 p.Article

First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology : A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityDYKE, Christopher K; STEINHUBL, Steven R; BECKER, Richard C et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 23, pp 2490-2497, issn 0009-7322, 8 p.Article

Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes : Results from 4 large clinical trialsGALLA, John M; MAHAFFEY, Kenneth W; SIMOONS, Maarten L et al.The American heart journal. 2005, Vol 151, Num 1, pp 16-24, issn 0002-8703, 9 p.Article

Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgeryHALABI, Abdul R; ALEXANDER, John H; SHAW, Linda K et al.The American journal of cardiology. 2005, Vol 96, Num 9, pp 1254-1259, issn 0002-9149, 6 p.Article

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: One-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarctionSINNAEVE, Peter R; ALEXANDER, John H; VAHANIAN, Alec et al.The American heart journal. 2004, Vol 147, Num 6, pp 993-998, issn 0002-8703, 6 p.Article

Platelet function and fibrinolytic agents: two sides of a coin?CALLAHAN, Kevin P; MALININ, Alex I; GURBEL, Paul A et al.Cardiology. 2001, Vol 95, Num 2, pp 55-60, issn 0008-6312Article

Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic ShockVAN DIEPEN, Sean; REYNOLDS, Harmony R; DAUERMAN, Harold L et al.Critical care medicine. 2014, Vol 42, Num 2, pp 281-288, issn 0090-3493, 8 p.Article

Surgical Treatment of Moderate Ischemic Mitral RegurgitationSMITH, Peter K; PUSKAS, John D; ACKER, Michael A et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2178-2188, issn 0028-4793, 11 p.Article

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialWALLENTIN, Lars; HIJAZI, Ziad; GRANGER, Christopher B et al.Circulation (New York, N.Y.). 2014, Vol 130, Num 21, pp 1847-1858, issn 0009-7322, 12 p.Article

Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trialBAHIT, Maria Cecilia; LOPES, Renato D; HANNA, Michael et al.International journal of cardiology. 2013, Vol 170, Num 2, pp 215-220, issn 0167-5273, 6 p.Article

Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsHESS, Connie N; BRODERICK, Samuel; LOPES, Renato D et al.The American heart journal. 2012, Vol 164, Num 4, pp 607-615, issn 0002-8703, 9 p.Article

Association Between Endoscopic vs Open Vein-Graft Harvesting and Mortality, Wound Complications, and Cardiovascular Events in Patients Undergoing CABG SurgeryWILLIAMS, Judson B; PETERSON, Eric D; MICHLER, Robert E et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 5, pp 475-484, issn 0098-7484, 10 p.Article

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialHOHNLOSER, Stefan H; HIJAZI, Ziad; GRANGER, Christopher B et al.European heart journal. 2012, Vol 33, Num 22, pp 2821-2830, issn 0195-668X, 10 p.Article

Impact of Perioperative Myocardial Infarction on Angiographic and Clinical Outcomes Following Coronary Artery Bypass Grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)YAU, James M; ALEXANDER, John H; HARRINGTON, Robert A et al.The American journal of cardiology. 2008, Vol 102, Num 5, pp 546-551, issn 0002-9149, 6 p.Article

  • Page / 3